Solel Partners LP Makes New $1.12 Million Investment in Humana Inc. (NYSE:HUM)

Solel Partners LP acquired a new stake in shares of Humana Inc. (NYSE:HUM) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,400 shares of the insurance provider’s stock, valued at approximately $1,116,000. Humana makes up approximately 0.2% of Solel Partners LP’s holdings, making the stock its 22nd biggest position.

Other hedge funds also recently made changes to their positions in the company. Transcend Capital Advisors LLC raised its position in Humana by 399.7% during the fourth quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock valued at $924,000 after purchasing an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC lifted its position in Humana by 6,647.5% in the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock worth $6,916,000 after buying an additional 26,856 shares during the last quarter. Retirement Systems of Alabama boosted its stake in Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock worth $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after acquiring an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC purchased a new position in shares of Humana during the fourth quarter worth approximately $244,000. 92.38% of the stock is owned by institutional investors.

Humana Trading Down 2.3 %

NYSE HUM opened at $256.11 on Friday. The stock’s fifty day moving average price is $266.20 and its 200-day moving average price is $270.62. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.68. The stock has a market cap of $30.91 billion, a P/E ratio of 25.74, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion during the quarter, compared to analysts’ expectations of $32 billion. During the same period in the previous year, the company earned $7.23 earnings per share. The business’s revenue for the quarter was up 8.4% compared to the same quarter last year. As a group, equities analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 annualized dividend and a yield of 1.38%. Humana’s dividend payout ratio is 35.58%.

Analyst Ratings Changes

Several research firms recently commented on HUM. Barclays increased their target price on shares of Humana from $270.00 to $322.00 and gave the company an “equal weight” rating in a report on Friday, April 11th. Morgan Stanley dropped their target price on Humana from $301.00 to $285.00 and set an “equal weight” rating for the company in a report on Wednesday, February 12th. Truist Financial boosted their price objective on Humana from $290.00 to $325.00 and gave the company a “hold” rating in a research report on Friday, April 11th. Cantor Fitzgerald restated a “neutral” rating and issued a $290.00 target price on shares of Humana in a report on Thursday. Finally, Piper Sandler upped their price target on shares of Humana from $270.00 to $288.00 and gave the company a “neutral” rating in a report on Wednesday, January 15th. Eighteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $287.76.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.